ENOB - Enochian Biosciences plunges after new short call from Hindenburg Research
Enochain Biosciences (ENOB) plummeted 36% after Hindenburg Research said it was short the firm. Hindenburg Research tweeted that it plans to release a report on the company's co-founder Serhat Gumrukcu next week. ENOB short interest is 17%.
For further details see:
Enochian Biosciences plunges after new short call from Hindenburg Research